Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
Authors
Keywords
-
Journal
DIABETES CARE
Volume 37, Issue 1, Pages 202-209
Publisher
American Diabetes Association
Online
2013-09-12
DOI
10.2337/dc13-0410
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patterns of Medication Initiation in Newly Diagnosed Diabetes Mellitus: Quality and Cost Implications
- (2012) Nihar R. Desai et al. AMERICAN JOURNAL OF MEDICINE
- Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young
- (2012) G. Thanabalasingham et al. DIABETES CARE
- The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes
- (2012) B. M. Shields et al. DIABETOLOGIA
- Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1- /Hepatocyte Nuclear Factor 4- Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes
- (2011) R. E. J. Besser et al. DIABETES CARE
- A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes
- (2011) G. Thanabalasingham et al. DIABETOLOGIA
- Clinical Characteristics and Diagnostic Criteria of Maturity-Onset Diabetes Of The Young (MODY) due to Molecular Anomalies of theHNF1AGene
- (2011) Christine Bellanné-Chantelot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Double Heterozygous Mutations Involving Both HNF1A/MODY3 and HNF4A/MODY1 Genes: A case report
- (2010) G. Forlani et al. DIABETES CARE
- Maturity-onset diabetes of the young (MODY): how many cases are we missing?
- (2010) B. M. Shields et al. DIABETOLOGIA
- Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations
- (2010) Stepanka Pruhova et al. PEDIATRIC DIABETES
- Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity-onset diabetes of the young
- (2009) H. J. B. H. Beijers et al. DIABETIC MEDICINE
- A genetic diagnosis ofHNF1Adiabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients
- (2009) M. Shepherd et al. DIABETIC MEDICINE
- What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?
- (2009) R Scott Braithwaite et al. MEDICAL CARE
- Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus
- (2009) Ethel Codner et al. PEDIATRIC DIABETES
- National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007
- (2008) G. Caleb Alexander et al. ARCHIVES OF INTERNAL MEDICINE
- Long-Term Follow-Up of Oral Glucose Tolerance Test-Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)
- (2008) D. Martin et al. DIABETES CARE
- Clinical implications of a molecular genetic classification of monogenic β-cell diabetes
- (2008) Rinki Murphy et al. Nature clinical practice. Endocrinology & metabolism
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started